nodes	percent_of_prediction	percent_of_DWPC	metapath
Afatinib—ABCG2—Hydrocortisone—atopic dermatitis	0.0745	0.183	CbGbCtD
Afatinib—ABCB1—Tacrolimus—atopic dermatitis	0.066	0.162	CbGbCtD
Afatinib—ABCB1—Loratadine—atopic dermatitis	0.0483	0.119	CbGbCtD
Afatinib—ABCG2—Dexamethasone—atopic dermatitis	0.0463	0.114	CbGbCtD
Afatinib—ABCB1—Methylprednisolone—atopic dermatitis	0.0442	0.109	CbGbCtD
Afatinib—ABCB1—Betamethasone—atopic dermatitis	0.0287	0.0706	CbGbCtD
Afatinib—ABCB1—Prednisolone—atopic dermatitis	0.0283	0.0697	CbGbCtD
Afatinib—ABCB1—Hydrocortisone—atopic dermatitis	0.0269	0.066	CbGbCtD
Afatinib—ABCB1—Prednisone—atopic dermatitis	0.0268	0.0658	CbGbCtD
Afatinib—ABCB1—Dexamethasone—atopic dermatitis	0.0167	0.0411	CbGbCtD
Afatinib—ERBB2—Everolimus—Tacrolimus—atopic dermatitis	0.0015	0.129	CbGdCrCtD
Afatinib—ERBB2—Everolimus—Pimecrolimus—atopic dermatitis	0.0015	0.129	CbGdCrCtD
Afatinib—Dermatitis—Fluocinonide—atopic dermatitis	0.000731	0.00231	CcSEcCtD
Afatinib—Insomnia—Loratadine—atopic dermatitis	0.000729	0.0023	CcSEcCtD
Afatinib—Headache—Fluocinonide—atopic dermatitis	0.000727	0.00229	CcSEcCtD
Afatinib—Eye disorder—Tacrolimus—atopic dermatitis	0.000724	0.00228	CcSEcCtD
Afatinib—Infection—Fluocinolone Acetonide—atopic dermatitis	0.00072	0.00227	CcSEcCtD
Afatinib—Diarrhoea—Dimenhydrinate—atopic dermatitis	0.000716	0.00226	CcSEcCtD
Afatinib—Diarrhoea—Diphenhydramine—atopic dermatitis	0.000716	0.00226	CcSEcCtD
Afatinib—Pruritus—Pimecrolimus—atopic dermatitis	0.000716	0.00226	CcSEcCtD
Afatinib—Nervous system disorder—Fluocinolone Acetonide—atopic dermatitis	0.00071	0.00224	CcSEcCtD
Afatinib—Dyspepsia—Loratadine—atopic dermatitis	0.000709	0.00224	CcSEcCtD
Afatinib—Mediastinal disorder—Tacrolimus—atopic dermatitis	0.000698	0.0022	CcSEcCtD
Afatinib—Gastrointestinal disorder—Loratadine—atopic dermatitis	0.000696	0.00219	CcSEcCtD
Afatinib—Fatigue—Loratadine—atopic dermatitis	0.000695	0.00219	CcSEcCtD
Afatinib—Diarrhoea—Pimecrolimus—atopic dermatitis	0.000692	0.00218	CcSEcCtD
Afatinib—Dizziness—Dimenhydrinate—atopic dermatitis	0.000692	0.00218	CcSEcCtD
Afatinib—Dizziness—Diphenhydramine—atopic dermatitis	0.000692	0.00218	CcSEcCtD
Afatinib—Constipation—Loratadine—atopic dermatitis	0.000689	0.00217	CcSEcCtD
Afatinib—Infection—Mometasone—atopic dermatitis	0.000687	0.00217	CcSEcCtD
Afatinib—Alopecia—Tacrolimus—atopic dermatitis	0.000685	0.00216	CcSEcCtD
Afatinib—Mental disorder—Tacrolimus—atopic dermatitis	0.000679	0.00214	CcSEcCtD
Afatinib—Malnutrition—Tacrolimus—atopic dermatitis	0.000675	0.00213	CcSEcCtD
Afatinib—Vomiting—Diphenhydramine—atopic dermatitis	0.000665	0.0021	CcSEcCtD
Afatinib—Vomiting—Dimenhydrinate—atopic dermatitis	0.000665	0.0021	CcSEcCtD
Afatinib—ERBB2—Triamcinolone—Desonide—atopic dermatitis	0.000665	0.0574	CbGdCrCtD
Afatinib—Dysgeusia—Tacrolimus—atopic dermatitis	0.000661	0.00208	CcSEcCtD
Afatinib—Rash—Diphenhydramine—atopic dermatitis	0.00066	0.00208	CcSEcCtD
Afatinib—Rash—Dimenhydrinate—atopic dermatitis	0.00066	0.00208	CcSEcCtD
Afatinib—Dermatitis—Diphenhydramine—atopic dermatitis	0.000659	0.00208	CcSEcCtD
Afatinib—Dermatitis—Dimenhydrinate—atopic dermatitis	0.000659	0.00208	CcSEcCtD
Afatinib—Dry skin—Prednisolone—atopic dermatitis	0.000656	0.00207	CcSEcCtD
Afatinib—Headache—Dimenhydrinate—atopic dermatitis	0.000656	0.00207	CcSEcCtD
Afatinib—Headache—Diphenhydramine—atopic dermatitis	0.000656	0.00207	CcSEcCtD
Afatinib—Back pain—Tacrolimus—atopic dermatitis	0.000652	0.00206	CcSEcCtD
Afatinib—Muscle spasms—Tacrolimus—atopic dermatitis	0.000649	0.00205	CcSEcCtD
Afatinib—Vomiting—Pimecrolimus—atopic dermatitis	0.000643	0.00203	CcSEcCtD
Afatinib—Dry skin—Hydrocortisone—atopic dermatitis	0.00064	0.00202	CcSEcCtD
Afatinib—Rash—Pimecrolimus—atopic dermatitis	0.000638	0.00201	CcSEcCtD
Afatinib—Dermatitis—Pimecrolimus—atopic dermatitis	0.000637	0.00201	CcSEcCtD
Afatinib—Body temperature increased—Loratadine—atopic dermatitis	0.000637	0.00201	CcSEcCtD
Afatinib—Hypokalaemia—Hydrocortisone—atopic dermatitis	0.000636	0.00201	CcSEcCtD
Afatinib—Headache—Pimecrolimus—atopic dermatitis	0.000634	0.002	CcSEcCtD
Afatinib—ERBB2—Desoximetasone—Desonide—atopic dermatitis	0.000631	0.0545	CbGdCrCtD
Afatinib—Gastrointestinal disorder—Fluocinolone Acetonide—atopic dermatitis	0.000625	0.00197	CcSEcCtD
Afatinib—Nausea—Dimenhydrinate—atopic dermatitis	0.000622	0.00196	CcSEcCtD
Afatinib—Nausea—Diphenhydramine—atopic dermatitis	0.000622	0.00196	CcSEcCtD
Afatinib—Sepsis—Prednisone—atopic dermatitis	0.000621	0.00196	CcSEcCtD
Afatinib—Dyspnoea—Mometasone—atopic dermatitis	0.000617	0.00194	CcSEcCtD
Afatinib—Alanine aminotransferase increased—Hydrocortisone—atopic dermatitis	0.000616	0.00194	CcSEcCtD
Afatinib—Dyspepsia—Mometasone—atopic dermatitis	0.000609	0.00192	CcSEcCtD
Afatinib—Decreased appetite—Mometasone—atopic dermatitis	0.000601	0.0019	CcSEcCtD
Afatinib—Nausea—Pimecrolimus—atopic dermatitis	0.000601	0.0019	CcSEcCtD
Afatinib—Fatigue—Mometasone—atopic dermatitis	0.000596	0.00188	CcSEcCtD
Afatinib—Cough—Tacrolimus—atopic dermatitis	0.000589	0.00186	CcSEcCtD
Afatinib—Alanine aminotransferase increased—Methylprednisolone—atopic dermatitis	0.000579	0.00183	CcSEcCtD
Afatinib—Asthenia—Loratadine—atopic dermatitis	0.000578	0.00182	CcSEcCtD
Afatinib—Body temperature increased—Fluocinolone Acetonide—atopic dermatitis	0.000573	0.00181	CcSEcCtD
Afatinib—Unspecified disorder of skin and subcutaneous tissue—Tacrolimus—atopic dermatitis	0.00057	0.0018	CcSEcCtD
Afatinib—Upper respiratory tract infection—Hydrocortisone—atopic dermatitis	0.000561	0.00177	CcSEcCtD
Afatinib—Diarrhoea—Loratadine—atopic dermatitis	0.000551	0.00174	CcSEcCtD
Afatinib—Dry skin—Dexamethasone—atopic dermatitis	0.000547	0.00173	CcSEcCtD
Afatinib—Dry skin—Betamethasone—atopic dermatitis	0.000547	0.00173	CcSEcCtD
Afatinib—Infection—Tacrolimus—atopic dermatitis	0.000547	0.00172	CcSEcCtD
Afatinib—Body temperature increased—Mometasone—atopic dermatitis	0.000547	0.00172	CcSEcCtD
Afatinib—Weight decreased—Hydrocortisone—atopic dermatitis	0.000546	0.00172	CcSEcCtD
Afatinib—Hypokalaemia—Betamethasone—atopic dermatitis	0.000543	0.00171	CcSEcCtD
Afatinib—Hypokalaemia—Dexamethasone—atopic dermatitis	0.000543	0.00171	CcSEcCtD
Afatinib—Nervous system disorder—Tacrolimus—atopic dermatitis	0.00054	0.0017	CcSEcCtD
Afatinib—Infestation NOS—Hydrocortisone—atopic dermatitis	0.000538	0.0017	CcSEcCtD
Afatinib—Infestation—Hydrocortisone—atopic dermatitis	0.000538	0.0017	CcSEcCtD
Afatinib—Conjunctivitis—Prednisolone—atopic dermatitis	0.000536	0.00169	CcSEcCtD
Afatinib—Skin disorder—Tacrolimus—atopic dermatitis	0.000535	0.00169	CcSEcCtD
Afatinib—Dizziness—Loratadine—atopic dermatitis	0.000533	0.00168	CcSEcCtD
Afatinib—ERBB2—Triamcinolone—Fluocinonide—atopic dermatitis	0.000532	0.0459	CbGdCrCtD
Afatinib—Upper respiratory tract infection—Triamcinolone—atopic dermatitis	0.000528	0.00167	CcSEcCtD
Afatinib—ERBB2—Triamcinolone—Fluocinolone Acetonide—atopic dermatitis	0.000517	0.0446	CbGdCrCtD
Afatinib—Pruritus—Fluocinolone Acetonide—atopic dermatitis	0.000512	0.00162	CcSEcCtD
Afatinib—Vomiting—Loratadine—atopic dermatitis	0.000512	0.00162	CcSEcCtD
Afatinib—Rash—Loratadine—atopic dermatitis	0.000508	0.0016	CcSEcCtD
Afatinib—Dermatitis—Loratadine—atopic dermatitis	0.000508	0.0016	CcSEcCtD
Afatinib—Infestation—Methylprednisolone—atopic dermatitis	0.000506	0.0016	CcSEcCtD
Afatinib—Infestation NOS—Methylprednisolone—atopic dermatitis	0.000506	0.0016	CcSEcCtD
Afatinib—ERBB2—Desoximetasone—Fluocinonide—atopic dermatitis	0.000506	0.0436	CbGdCrCtD
Afatinib—Headache—Loratadine—atopic dermatitis	0.000505	0.00159	CcSEcCtD
Afatinib—Insomnia—Tacrolimus—atopic dermatitis	0.000498	0.00157	CcSEcCtD
Afatinib—Asthenia—Mometasone—atopic dermatitis	0.000496	0.00157	CcSEcCtD
Afatinib—Diarrhoea—Fluocinolone Acetonide—atopic dermatitis	0.000496	0.00156	CcSEcCtD
Afatinib—Conjunctivitis—Triamcinolone—atopic dermatitis	0.000493	0.00155	CcSEcCtD
Afatinib—ERBB2—Desoximetasone—Fluocinolone Acetonide—atopic dermatitis	0.000491	0.0424	CbGdCrCtD
Afatinib—Dyspnoea—Tacrolimus—atopic dermatitis	0.000491	0.00155	CcSEcCtD
Afatinib—Pruritus—Mometasone—atopic dermatitis	0.000489	0.00154	CcSEcCtD
Afatinib—Dyspepsia—Tacrolimus—atopic dermatitis	0.000485	0.00153	CcSEcCtD
Afatinib—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.000479	0.00151	CcSEcCtD
Afatinib—Nausea—Loratadine—atopic dermatitis	0.000479	0.00151	CcSEcCtD
Afatinib—Decreased appetite—Tacrolimus—atopic dermatitis	0.000479	0.00151	CcSEcCtD
Afatinib—Epistaxis—Triamcinolone—atopic dermatitis	0.000478	0.00151	CcSEcCtD
Afatinib—Dry skin—Prednisone—atopic dermatitis	0.000477	0.0015	CcSEcCtD
Afatinib—Gastrointestinal disorder—Tacrolimus—atopic dermatitis	0.000475	0.0015	CcSEcCtD
Afatinib—Connective tissue disorder—Hydrocortisone—atopic dermatitis	0.000475	0.0015	CcSEcCtD
Afatinib—Fatigue—Tacrolimus—atopic dermatitis	0.000475	0.0015	CcSEcCtD
Afatinib—Diarrhoea—Mometasone—atopic dermatitis	0.000473	0.00149	CcSEcCtD
Afatinib—Hypokalaemia—Prednisone—atopic dermatitis	0.000473	0.00149	CcSEcCtD
Afatinib—Constipation—Tacrolimus—atopic dermatitis	0.000471	0.00148	CcSEcCtD
Afatinib—Weight decreased—Betamethasone—atopic dermatitis	0.000467	0.00147	CcSEcCtD
Afatinib—Weight decreased—Dexamethasone—atopic dermatitis	0.000467	0.00147	CcSEcCtD
Afatinib—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.000461	0.00145	CcSEcCtD
Afatinib—Alanine aminotransferase increased—Prednisone—atopic dermatitis	0.000459	0.00145	CcSEcCtD
Afatinib—Rash—Fluocinolone Acetonide—atopic dermatitis	0.000457	0.00144	CcSEcCtD
Afatinib—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.000456	0.00144	CcSEcCtD
Afatinib—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000454	0.00143	CcSEcCtD
Afatinib—ERBB2—Exemestane—Methylprednisolone—atopic dermatitis	0.000453	0.0391	CbGdCrCtD
Afatinib—Eye disorder—Hydrocortisone—atopic dermatitis	0.000452	0.00142	CcSEcCtD
Afatinib—ERBB2—neck—atopic dermatitis	0.000452	0.229	CbGeAlD
Afatinib—Conjunctivitis—Dexamethasone—atopic dermatitis	0.000447	0.00141	CcSEcCtD
Afatinib—Conjunctivitis—Betamethasone—atopic dermatitis	0.000447	0.00141	CcSEcCtD
Afatinib—Connective tissue disorder—Methylprednisolone—atopic dermatitis	0.000446	0.00141	CcSEcCtD
Afatinib—Vomiting—Mometasone—atopic dermatitis	0.00044	0.00139	CcSEcCtD
Afatinib—Rash—Mometasone—atopic dermatitis	0.000436	0.00138	CcSEcCtD
Afatinib—Dermatitis—Mometasone—atopic dermatitis	0.000436	0.00137	CcSEcCtD
Afatinib—Body temperature increased—Tacrolimus—atopic dermatitis	0.000435	0.00137	CcSEcCtD
Afatinib—Headache—Mometasone—atopic dermatitis	0.000433	0.00137	CcSEcCtD
Afatinib—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.00043	0.00136	CcSEcCtD
Afatinib—Eye disorder—Methylprednisolone—atopic dermatitis	0.000424	0.00134	CcSEcCtD
Afatinib—Mental disorder—Hydrocortisone—atopic dermatitis	0.000423	0.00134	CcSEcCtD
Afatinib—Malnutrition—Hydrocortisone—atopic dermatitis	0.000421	0.00133	CcSEcCtD
Afatinib—ERBB2—Exemestane—Prednisone—atopic dermatitis	0.000413	0.0356	CbGdCrCtD
Afatinib—ERBB2—Triamcinolone—Mometasone—atopic dermatitis	0.000413	0.0356	CbGdCrCtD
Afatinib—Nausea—Mometasone—atopic dermatitis	0.000411	0.0013	CcSEcCtD
Afatinib—Mediastinal disorder—Methylprednisolone—atopic dermatitis	0.000409	0.00129	CcSEcCtD
Afatinib—Weight decreased—Prednisone—atopic dermatitis	0.000407	0.00128	CcSEcCtD
Afatinib—ERBB2—Exemestane—Prednisolone—atopic dermatitis	0.000403	0.0348	CbGdCrCtD
Afatinib—Mental disorder—Methylprednisolone—atopic dermatitis	0.000398	0.00125	CcSEcCtD
Afatinib—Malnutrition—Methylprednisolone—atopic dermatitis	0.000395	0.00125	CcSEcCtD
Afatinib—Asthenia—Tacrolimus—atopic dermatitis	0.000395	0.00125	CcSEcCtD
Afatinib—ERBB2—Desoximetasone—Mometasone—atopic dermatitis	0.000392	0.0338	CbGdCrCtD
Afatinib—Pruritus—Tacrolimus—atopic dermatitis	0.000389	0.00123	CcSEcCtD
Afatinib—Dysgeusia—Triamcinolone—atopic dermatitis	0.000388	0.00122	CcSEcCtD
Afatinib—Eye disorder—Dexamethasone—atopic dermatitis	0.000386	0.00122	CcSEcCtD
Afatinib—Eye disorder—Betamethasone—atopic dermatitis	0.000386	0.00122	CcSEcCtD
Afatinib—Back pain—Triamcinolone—atopic dermatitis	0.000383	0.00121	CcSEcCtD
Afatinib—Diarrhoea—Tacrolimus—atopic dermatitis	0.000377	0.00119	CcSEcCtD
Afatinib—Alopecia—Betamethasone—atopic dermatitis	0.000365	0.00115	CcSEcCtD
Afatinib—Alopecia—Dexamethasone—atopic dermatitis	0.000365	0.00115	CcSEcCtD
Afatinib—Dizziness—Tacrolimus—atopic dermatitis	0.000364	0.00115	CcSEcCtD
Afatinib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	0.000356	0.00112	CcSEcCtD
Afatinib—Connective tissue disorder—Prednisone—atopic dermatitis	0.000353	0.00111	CcSEcCtD
Afatinib—Vomiting—Tacrolimus—atopic dermatitis	0.00035	0.0011	CcSEcCtD
Afatinib—Rash—Tacrolimus—atopic dermatitis	0.000347	0.00109	CcSEcCtD
Afatinib—Dermatitis—Tacrolimus—atopic dermatitis	0.000347	0.00109	CcSEcCtD
Afatinib—Cough—Triamcinolone—atopic dermatitis	0.000346	0.00109	CcSEcCtD
Afatinib—Headache—Tacrolimus—atopic dermatitis	0.000345	0.00109	CcSEcCtD
Afatinib—Infection—Hydrocortisone—atopic dermatitis	0.000341	0.00108	CcSEcCtD
Afatinib—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000337	0.00106	CcSEcCtD
Afatinib—Eye disorder—Prednisone—atopic dermatitis	0.000336	0.00106	CcSEcCtD
Afatinib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.000334	0.00105	CcSEcCtD
Afatinib—Skin disorder—Hydrocortisone—atopic dermatitis	0.000334	0.00105	CcSEcCtD
Afatinib—Nausea—Tacrolimus—atopic dermatitis	0.000327	0.00103	CcSEcCtD
Afatinib—Infection—Triamcinolone—atopic dermatitis	0.000321	0.00101	CcSEcCtD
Afatinib—Infection—Methylprednisolone—atopic dermatitis	0.000321	0.00101	CcSEcCtD
Afatinib—Insomnia—Prednisolone—atopic dermatitis	0.000318	0.001	CcSEcCtD
Afatinib—Alopecia—Prednisone—atopic dermatitis	0.000318	0.001	CcSEcCtD
Afatinib—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.000316	0.000998	CcSEcCtD
Afatinib—Mental disorder—Prednisone—atopic dermatitis	0.000315	0.000994	CcSEcCtD
Afatinib—Skin disorder—Methylprednisolone—atopic dermatitis	0.000313	0.000988	CcSEcCtD
Afatinib—Malnutrition—Prednisone—atopic dermatitis	0.000313	0.000987	CcSEcCtD
Afatinib—Insomnia—Hydrocortisone—atopic dermatitis	0.000311	0.00098	CcSEcCtD
Afatinib—Dyspepsia—Hydrocortisone—atopic dermatitis	0.000302	0.000953	CcSEcCtD
Afatinib—Decreased appetite—Hydrocortisone—atopic dermatitis	0.000299	0.000942	CcSEcCtD
Afatinib—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000296	0.000935	CcSEcCtD
Afatinib—Fatigue—Hydrocortisone—atopic dermatitis	0.000296	0.000934	CcSEcCtD
Afatinib—Insomnia—Triamcinolone—atopic dermatitis	0.000292	0.000922	CcSEcCtD
Afatinib—ERBB2—skin of body—atopic dermatitis	0.000292	0.148	CbGeAlD
Afatinib—Insomnia—Methylprednisolone—atopic dermatitis	0.000292	0.00092	CcSEcCtD
Afatinib—Infection—Dexamethasone—atopic dermatitis	0.000291	0.000919	CcSEcCtD
Afatinib—Infection—Betamethasone—atopic dermatitis	0.000291	0.000919	CcSEcCtD
Afatinib—Dyspnoea—Triamcinolone—atopic dermatitis	0.000288	0.000909	CcSEcCtD
Afatinib—Nervous system disorder—Dexamethasone—atopic dermatitis	0.000288	0.000907	CcSEcCtD
Afatinib—Nervous system disorder—Betamethasone—atopic dermatitis	0.000288	0.000907	CcSEcCtD
Afatinib—Dyspepsia—Triamcinolone—atopic dermatitis	0.000285	0.000898	CcSEcCtD
Afatinib—Dyspepsia—Methylprednisolone—atopic dermatitis	0.000284	0.000896	CcSEcCtD
Afatinib—Fatigue—Triamcinolone—atopic dermatitis	0.000279	0.000879	CcSEcCtD
Afatinib—Fatigue—Methylprednisolone—atopic dermatitis	0.000278	0.000877	CcSEcCtD
Afatinib—Body temperature increased—Hydrocortisone—atopic dermatitis	0.000271	0.000856	CcSEcCtD
Afatinib—Insomnia—Dexamethasone—atopic dermatitis	0.000265	0.000837	CcSEcCtD
Afatinib—Insomnia—Betamethasone—atopic dermatitis	0.000265	0.000837	CcSEcCtD
Afatinib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	0.000265	0.000835	CcSEcCtD
Afatinib—ERBB2—Triamcinolone—Hydrocortisone—atopic dermatitis	0.000261	0.0225	CbGdCrCtD
Afatinib—Dyspepsia—Betamethasone—atopic dermatitis	0.000258	0.000815	CcSEcCtD
Afatinib—Dyspepsia—Dexamethasone—atopic dermatitis	0.000258	0.000815	CcSEcCtD
Afatinib—Body temperature increased—Triamcinolone—atopic dermatitis	0.000256	0.000806	CcSEcCtD
Afatinib—Decreased appetite—Dexamethasone—atopic dermatitis	0.000255	0.000804	CcSEcCtD
Afatinib—Decreased appetite—Betamethasone—atopic dermatitis	0.000255	0.000804	CcSEcCtD
Afatinib—Infection—Prednisone—atopic dermatitis	0.000254	0.000801	CcSEcCtD
Afatinib—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.000253	0.000799	CcSEcCtD
Afatinib—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.000253	0.000799	CcSEcCtD
Afatinib—Fatigue—Dexamethasone—atopic dermatitis	0.000253	0.000798	CcSEcCtD
Afatinib—Fatigue—Betamethasone—atopic dermatitis	0.000253	0.000798	CcSEcCtD
Afatinib—Nervous system disorder—Prednisone—atopic dermatitis	0.000251	0.00079	CcSEcCtD
Afatinib—Skin disorder—Prednisone—atopic dermatitis	0.000248	0.000783	CcSEcCtD
Afatinib—ERBB2—Desoximetasone—Hydrocortisone—atopic dermatitis	0.000248	0.0214	CbGdCrCtD
Afatinib—ERBB2—Triamcinolone—Methylprednisolone—atopic dermatitis	0.000247	0.0213	CbGdCrCtD
Afatinib—Asthenia—Hydrocortisone—atopic dermatitis	0.000246	0.000777	CcSEcCtD
Afatinib—Pruritus—Hydrocortisone—atopic dermatitis	0.000243	0.000766	CcSEcCtD
Afatinib—ERBB2—Triamcinolone—Dexamethasone—atopic dermatitis	0.000243	0.0209	CbGdCrCtD
Afatinib—ERBB2—Triamcinolone—Betamethasone—atopic dermatitis	0.000243	0.0209	CbGdCrCtD
Afatinib—Diarrhoea—Hydrocortisone—atopic dermatitis	0.000235	0.000741	CcSEcCtD
Afatinib—ERBB2—Desoximetasone—Methylprednisolone—atopic dermatitis	0.000234	0.0202	CbGdCrCtD
Afatinib—Dizziness—Prednisolone—atopic dermatitis	0.000233	0.000733	CcSEcCtD
Afatinib—Asthenia—Triamcinolone—atopic dermatitis	0.000232	0.000732	CcSEcCtD
Afatinib—Body temperature increased—Dexamethasone—atopic dermatitis	0.000232	0.000732	CcSEcCtD
Afatinib—Body temperature increased—Betamethasone—atopic dermatitis	0.000232	0.000732	CcSEcCtD
Afatinib—Asthenia—Methylprednisolone—atopic dermatitis	0.000231	0.00073	CcSEcCtD
Afatinib—Insomnia—Prednisone—atopic dermatitis	0.000231	0.000729	CcSEcCtD
Afatinib—ERBB2—Desoximetasone—Betamethasone—atopic dermatitis	0.00023	0.0199	CbGdCrCtD
Afatinib—ERBB2—Desoximetasone—Dexamethasone—atopic dermatitis	0.00023	0.0199	CbGdCrCtD
Afatinib—Pruritus—Triamcinolone—atopic dermatitis	0.000229	0.000722	CcSEcCtD
Afatinib—Pruritus—Methylprednisolone—atopic dermatitis	0.000228	0.00072	CcSEcCtD
Afatinib—Dizziness—Hydrocortisone—atopic dermatitis	0.000227	0.000716	CcSEcCtD
Afatinib—ERBB2—Desoximetasone—Triamcinolone—atopic dermatitis	0.000225	0.0194	CbGdCrCtD
Afatinib—ERBB2—Triamcinolone—Prednisone—atopic dermatitis	0.000225	0.0194	CbGdCrCtD
Afatinib—Dyspepsia—Prednisone—atopic dermatitis	0.000225	0.000709	CcSEcCtD
Afatinib—Decreased appetite—Prednisone—atopic dermatitis	0.000222	0.000701	CcSEcCtD
Afatinib—Rash—Prednisolone—atopic dermatitis	0.000222	0.000699	CcSEcCtD
Afatinib—Dermatitis—Prednisolone—atopic dermatitis	0.000222	0.000699	CcSEcCtD
Afatinib—Diarrhoea—Methylprednisolone—atopic dermatitis	0.000221	0.000696	CcSEcCtD
Afatinib—Fatigue—Prednisone—atopic dermatitis	0.00022	0.000695	CcSEcCtD
Afatinib—Headache—Prednisolone—atopic dermatitis	0.00022	0.000695	CcSEcCtD
Afatinib—EPHA6—head—atopic dermatitis	0.00022	0.112	CbGeAlD
Afatinib—ERBB2—Triamcinolone—Prednisolone—atopic dermatitis	0.00022	0.019	CbGdCrCtD
Afatinib—Constipation—Prednisone—atopic dermatitis	0.000219	0.000689	CcSEcCtD
Afatinib—Vomiting—Hydrocortisone—atopic dermatitis	0.000218	0.000689	CcSEcCtD
Afatinib—Rash—Hydrocortisone—atopic dermatitis	0.000217	0.000683	CcSEcCtD
Afatinib—Dermatitis—Hydrocortisone—atopic dermatitis	0.000216	0.000682	CcSEcCtD
Afatinib—Headache—Hydrocortisone—atopic dermatitis	0.000215	0.000679	CcSEcCtD
Afatinib—Dizziness—Triamcinolone—atopic dermatitis	0.000214	0.000674	CcSEcCtD
Afatinib—ERBB2—Desoximetasone—Prednisone—atopic dermatitis	0.000214	0.0184	CbGdCrCtD
Afatinib—Dizziness—Methylprednisolone—atopic dermatitis	0.000213	0.000673	CcSEcCtD
Afatinib—PHKG2—head—atopic dermatitis	0.000212	0.108	CbGeAlD
Afatinib—Asthenia—Dexamethasone—atopic dermatitis	0.000211	0.000664	CcSEcCtD
Afatinib—Asthenia—Betamethasone—atopic dermatitis	0.000211	0.000664	CcSEcCtD
Afatinib—Nausea—Prednisolone—atopic dermatitis	0.000209	0.000659	CcSEcCtD
Afatinib—ERBB2—Desoximetasone—Prednisolone—atopic dermatitis	0.000209	0.018	CbGdCrCtD
Afatinib—Pruritus—Dexamethasone—atopic dermatitis	0.000208	0.000655	CcSEcCtD
Afatinib—Pruritus—Betamethasone—atopic dermatitis	0.000208	0.000655	CcSEcCtD
Afatinib—Vomiting—Triamcinolone—atopic dermatitis	0.000206	0.000648	CcSEcCtD
Afatinib—Vomiting—Methylprednisolone—atopic dermatitis	0.000205	0.000647	CcSEcCtD
Afatinib—Nausea—Hydrocortisone—atopic dermatitis	0.000204	0.000643	CcSEcCtD
Afatinib—Rash—Triamcinolone—atopic dermatitis	0.000204	0.000643	CcSEcCtD
Afatinib—Dermatitis—Triamcinolone—atopic dermatitis	0.000204	0.000642	CcSEcCtD
Afatinib—Rash—Methylprednisolone—atopic dermatitis	0.000203	0.000642	CcSEcCtD
Afatinib—Dermatitis—Methylprednisolone—atopic dermatitis	0.000203	0.000641	CcSEcCtD
Afatinib—Headache—Triamcinolone—atopic dermatitis	0.000203	0.000639	CcSEcCtD
Afatinib—Headache—Methylprednisolone—atopic dermatitis	0.000202	0.000637	CcSEcCtD
Afatinib—Body temperature increased—Prednisone—atopic dermatitis	0.000202	0.000637	CcSEcCtD
Afatinib—Diarrhoea—Dexamethasone—atopic dermatitis	0.000201	0.000633	CcSEcCtD
Afatinib—Diarrhoea—Betamethasone—atopic dermatitis	0.000201	0.000633	CcSEcCtD
Afatinib—Dizziness—Dexamethasone—atopic dermatitis	0.000194	0.000612	CcSEcCtD
Afatinib—Dizziness—Betamethasone—atopic dermatitis	0.000194	0.000612	CcSEcCtD
Afatinib—Nausea—Triamcinolone—atopic dermatitis	0.000192	0.000606	CcSEcCtD
Afatinib—Nausea—Methylprednisolone—atopic dermatitis	0.000192	0.000604	CcSEcCtD
Afatinib—ERBB2—head—atopic dermatitis	0.000191	0.0969	CbGeAlD
Afatinib—ERBB4—head—atopic dermatitis	0.000191	0.0969	CbGeAlD
Afatinib—Vomiting—Betamethasone—atopic dermatitis	0.000187	0.000588	CcSEcCtD
Afatinib—Vomiting—Dexamethasone—atopic dermatitis	0.000187	0.000588	CcSEcCtD
Afatinib—Rash—Betamethasone—atopic dermatitis	0.000185	0.000583	CcSEcCtD
Afatinib—Rash—Dexamethasone—atopic dermatitis	0.000185	0.000583	CcSEcCtD
Afatinib—Dermatitis—Betamethasone—atopic dermatitis	0.000185	0.000583	CcSEcCtD
Afatinib—Dermatitis—Dexamethasone—atopic dermatitis	0.000185	0.000583	CcSEcCtD
Afatinib—Headache—Dexamethasone—atopic dermatitis	0.000184	0.00058	CcSEcCtD
Afatinib—Headache—Betamethasone—atopic dermatitis	0.000184	0.00058	CcSEcCtD
Afatinib—DYRK1A—head—atopic dermatitis	0.000184	0.0933	CbGeAlD
Afatinib—Asthenia—Prednisone—atopic dermatitis	0.000183	0.000578	CcSEcCtD
Afatinib—Pruritus—Prednisone—atopic dermatitis	0.000181	0.00057	CcSEcCtD
Afatinib—Diarrhoea—Prednisone—atopic dermatitis	0.000175	0.000551	CcSEcCtD
Afatinib—Nausea—Betamethasone—atopic dermatitis	0.000174	0.00055	CcSEcCtD
Afatinib—Nausea—Dexamethasone—atopic dermatitis	0.000174	0.00055	CcSEcCtD
Afatinib—Dizziness—Prednisone—atopic dermatitis	0.000169	0.000533	CcSEcCtD
Afatinib—Vomiting—Prednisone—atopic dermatitis	0.000162	0.000512	CcSEcCtD
Afatinib—Rash—Prednisone—atopic dermatitis	0.000161	0.000508	CcSEcCtD
Afatinib—Dermatitis—Prednisone—atopic dermatitis	0.000161	0.000508	CcSEcCtD
Afatinib—Headache—Prednisone—atopic dermatitis	0.00016	0.000505	CcSEcCtD
Afatinib—Nausea—Prednisone—atopic dermatitis	0.000152	0.000479	CcSEcCtD
Afatinib—ERBB2—Levonorgestrel—Hydrocortisone—atopic dermatitis	0.000145	0.0125	CbGdCrCtD
Afatinib—ABL1—skin of body—atopic dermatitis	0.000122	0.0622	CbGeAlD
Afatinib—ABL1—head—atopic dermatitis	7.99e-05	0.0406	CbGeAlD
Afatinib—EGFR—Signaling by GPCR—TAC1—atopic dermatitis	6.91e-05	0.000263	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—NPS—atopic dermatitis	6.91e-05	0.000263	CbGpPWpGaD
Afatinib—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	6.9e-05	0.000263	CbGpPWpGaD
Afatinib—ABL1—Immune System—IL5—atopic dermatitis	6.87e-05	0.000261	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—CCR3—atopic dermatitis	6.85e-05	0.000261	CbGpPWpGaD
Afatinib—LCK—Disease—SLC11A1—atopic dermatitis	6.83e-05	0.00026	CbGpPWpGaD
Afatinib—ERBB2—Immune System—NFKBIA—atopic dermatitis	6.81e-05	0.000259	CbGpPWpGaD
Afatinib—EGFR—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	6.79e-05	0.000258	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—CXCR3—atopic dermatitis	6.78e-05	0.000258	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—CD8A—atopic dermatitis	6.74e-05	0.000257	CbGpPWpGaD
Afatinib—LCK—Signaling by SCF-KIT—IL6—atopic dermatitis	6.73e-05	0.000256	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—CCL17—atopic dermatitis	6.72e-05	0.000256	CbGpPWpGaD
Afatinib—ERBB4—Immune System—NFKBIA—atopic dermatitis	6.7e-05	0.000255	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—CXCL10—atopic dermatitis	6.69e-05	0.000255	CbGpPWpGaD
Afatinib—EGFR—Downstream signaling of activated FGFR—IL6—atopic dermatitis	6.68e-05	0.000254	CbGpPWpGaD
Afatinib—LCK—Cytokine Signaling in Immune system—IL1B—atopic dermatitis	6.64e-05	0.000253	CbGpPWpGaD
Afatinib—LCK—Cytokine Signaling in Immune system—IL2—atopic dermatitis	6.62e-05	0.000252	CbGpPWpGaD
Afatinib—ABL1—Innate Immune System—NFKBIA—atopic dermatitis	6.61e-05	0.000252	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—CXCL10—atopic dermatitis	6.59e-05	0.000251	CbGpPWpGaD
Afatinib—EGFR—Signaling by ERBB4—IL6—atopic dermatitis	6.58e-05	0.00025	CbGpPWpGaD
Afatinib—ERBB2—Developmental Biology—TNF—atopic dermatitis	6.57e-05	0.00025	CbGpPWpGaD
Afatinib—ABL1—Immune System—TLR2—atopic dermatitis	6.55e-05	0.000249	CbGpPWpGaD
Afatinib—BLK—Immune System—NFKBIA—atopic dermatitis	6.45e-05	0.000245	CbGpPWpGaD
Afatinib—IRAK1—Immune System—IL18—atopic dermatitis	6.44e-05	0.000245	CbGpPWpGaD
Afatinib—LCK—Downstream signaling of activated FGFR—IL6—atopic dermatitis	6.44e-05	0.000245	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—IL5—atopic dermatitis	6.42e-05	0.000245	CbGpPWpGaD
Afatinib—ABCB1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	6.4e-05	0.000244	CbGpPWpGaD
Afatinib—IRAK1—Immune System—CD8A—atopic dermatitis	6.35e-05	0.000242	CbGpPWpGaD
Afatinib—LCK—Signaling by ERBB4—IL6—atopic dermatitis	6.34e-05	0.000241	CbGpPWpGaD
Afatinib—EGFR—Downstream signal transduction—IL6—atopic dermatitis	6.28e-05	0.000239	CbGpPWpGaD
Afatinib—IRAK1—Innate Immune System—CD4—atopic dermatitis	6.26e-05	0.000238	CbGpPWpGaD
Afatinib—EGFR—Signaling by FGFR—IL6—atopic dermatitis	6.25e-05	0.000238	CbGpPWpGaD
Afatinib—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	6.23e-05	0.000237	CbGpPWpGaD
Afatinib—EGFR—Signaling by ERBB2—IL6—atopic dermatitis	6.22e-05	0.000237	CbGpPWpGaD
Afatinib—EGFR—Signaling by NGF—MAPK8—atopic dermatitis	6.21e-05	0.000236	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—KIF3A—atopic dermatitis	6.21e-05	0.000236	CbGpPWpGaD
Afatinib—EGFR—Immune System—CASP1—atopic dermatitis	6.19e-05	0.000236	CbGpPWpGaD
Afatinib—EGFR—DAP12 signaling—IL6—atopic dermatitis	6.19e-05	0.000236	CbGpPWpGaD
Afatinib—ABL1—Immune System—CD79A—atopic dermatitis	6.16e-05	0.000234	CbGpPWpGaD
Afatinib—ERBB2—Immune System—CASP8—atopic dermatitis	6.14e-05	0.000234	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—TAC1—atopic dermatitis	6.1e-05	0.000232	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—NPS—atopic dermatitis	6.1e-05	0.000232	CbGpPWpGaD
Afatinib—LCK—Downstream signal transduction—IL6—atopic dermatitis	6.05e-05	0.00023	CbGpPWpGaD
Afatinib—ERBB4—Immune System—CASP8—atopic dermatitis	6.05e-05	0.00023	CbGpPWpGaD
Afatinib—IRAK1—Cytokine Signaling in Immune system—IL6—atopic dermatitis	6.03e-05	0.00023	CbGpPWpGaD
Afatinib—LCK—Signaling by FGFR—IL6—atopic dermatitis	6.02e-05	0.000229	CbGpPWpGaD
Afatinib—LCK—Signaling by ERBB2—IL6—atopic dermatitis	5.99e-05	0.000228	CbGpPWpGaD
Afatinib—LCK—Signaling by NGF—MAPK8—atopic dermatitis	5.99e-05	0.000228	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—CXCR3—atopic dermatitis	5.99e-05	0.000228	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—KIF3A—atopic dermatitis	5.99e-05	0.000228	CbGpPWpGaD
Afatinib—LCK—Immune System—CASP1—atopic dermatitis	5.97e-05	0.000227	CbGpPWpGaD
Afatinib—LCK—DAP12 signaling—IL6—atopic dermatitis	5.97e-05	0.000227	CbGpPWpGaD
Afatinib—ABL1—Innate Immune System—CASP8—atopic dermatitis	5.96e-05	0.000227	CbGpPWpGaD
Afatinib—IRAK1—Signaling by NGF—IL6—atopic dermatitis	5.93e-05	0.000226	CbGpPWpGaD
Afatinib—EGFR—Immune System—IL5—atopic dermatitis	5.87e-05	0.000223	CbGpPWpGaD
Afatinib—EGFR—Fc epsilon receptor (FCERI) signaling—IL6—atopic dermatitis	5.82e-05	0.000222	CbGpPWpGaD
Afatinib—EGFR—Signaling by FGFR in disease—IL6—atopic dermatitis	5.82e-05	0.000222	CbGpPWpGaD
Afatinib—EGFR—DAP12 interactions—IL6—atopic dermatitis	5.82e-05	0.000222	CbGpPWpGaD
Afatinib—BLK—Immune System—CASP8—atopic dermatitis	5.82e-05	0.000221	CbGpPWpGaD
Afatinib—EGFR—Signaling by EGFR—IL6—atopic dermatitis	5.77e-05	0.00022	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—CCL5—atopic dermatitis	5.76e-05	0.000219	CbGpPWpGaD
Afatinib—ABCG2—Transmembrane transport of small molecules—PPARA—atopic dermatitis	5.73e-05	0.000218	CbGpPWpGaD
Afatinib—EGFR—Signaling by EGFR in Cancer—IL6—atopic dermatitis	5.72e-05	0.000218	CbGpPWpGaD
Afatinib—EGFR—Signaling by PDGF—IL6—atopic dermatitis	5.7e-05	0.000217	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—CCL5—atopic dermatitis	5.67e-05	0.000216	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—IL5—atopic dermatitis	5.67e-05	0.000216	CbGpPWpGaD
Afatinib—LCK—Immune System—IL5—atopic dermatitis	5.66e-05	0.000215	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—NFKBIA—atopic dermatitis	5.65e-05	0.000215	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—CCL11—atopic dermatitis	5.62e-05	0.000214	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—CMA1—atopic dermatitis	5.62e-05	0.000214	CbGpPWpGaD
Afatinib—LCK—DAP12 interactions—IL6—atopic dermatitis	5.61e-05	0.000214	CbGpPWpGaD
Afatinib—LCK—Signaling by FGFR in disease—IL6—atopic dermatitis	5.61e-05	0.000214	CbGpPWpGaD
Afatinib—LCK—Fc epsilon receptor (FCERI) signaling—IL6—atopic dermatitis	5.61e-05	0.000214	CbGpPWpGaD
Afatinib—EGFR—Immune System—TLR2—atopic dermatitis	5.6e-05	0.000213	CbGpPWpGaD
Afatinib—LCK—Signaling by EGFR—IL6—atopic dermatitis	5.56e-05	0.000212	CbGpPWpGaD
Afatinib—LCK—Signaling by EGFR in Cancer—IL6—atopic dermatitis	5.51e-05	0.00021	CbGpPWpGaD
Afatinib—LCK—Signaling by PDGF—IL6—atopic dermatitis	5.49e-05	0.000209	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—CXCL10—atopic dermatitis	5.48e-05	0.000208	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—NFKBIA—atopic dermatitis	5.44e-05	0.000207	CbGpPWpGaD
Afatinib—EGFR—Adaptive Immune System—NFKBIA—atopic dermatitis	5.42e-05	0.000206	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—CCL11—atopic dermatitis	5.41e-05	0.000206	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—CMA1—atopic dermatitis	5.41e-05	0.000206	CbGpPWpGaD
Afatinib—LCK—Immune System—TLR2—atopic dermatitis	5.4e-05	0.000205	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—NGF—atopic dermatitis	5.33e-05	0.000203	CbGpPWpGaD
Afatinib—ERBB2—Developmental Biology—IL6—atopic dermatitis	5.3e-05	0.000202	CbGpPWpGaD
Afatinib—IRAK1—Innate Immune System—MAPK8—atopic dermatitis	5.3e-05	0.000202	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—STAT6—atopic dermatitis	5.28e-05	0.000201	CbGpPWpGaD
Afatinib—EGFR—Immune System—CD79A—atopic dermatitis	5.26e-05	0.0002	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—NGF—atopic dermatitis	5.26e-05	0.0002	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—NFKBIA—atopic dermatitis	5.23e-05	0.000199	CbGpPWpGaD
Afatinib—ERBB2—Immune System—IFNG—atopic dermatitis	5.22e-05	0.000199	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—CCR5—atopic dermatitis	5.19e-05	0.000198	CbGpPWpGaD
Afatinib—EGFR—NGF signalling via TRKA from the plasma membrane—IL6—atopic dermatitis	5.16e-05	0.000196	CbGpPWpGaD
Afatinib—ERBB4—Immune System—IFNG—atopic dermatitis	5.14e-05	0.000196	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—CCR5—atopic dermatitis	5.11e-05	0.000195	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—CASP8—atopic dermatitis	5.09e-05	0.000194	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—STAT6—atopic dermatitis	5.09e-05	0.000194	CbGpPWpGaD
Afatinib—PHKG2—Disease—IL6—atopic dermatitis	5.08e-05	0.000193	CbGpPWpGaD
Afatinib—LCK—Immune System—CD79A—atopic dermatitis	5.07e-05	0.000193	CbGpPWpGaD
Afatinib—ABL1—Immune System—IL18—atopic dermatitis	5.04e-05	0.000192	CbGpPWpGaD
Afatinib—ERBB2—Immune System—CD4—atopic dermatitis	5.04e-05	0.000192	CbGpPWpGaD
Afatinib—ABL1—Hemostasis—IL2—atopic dermatitis	5e-05	0.00019	CbGpPWpGaD
Afatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	4.98e-05	0.00019	CbGpPWpGaD
Afatinib—LCK—NGF signalling via TRKA from the plasma membrane—IL6—atopic dermatitis	4.97e-05	0.000189	CbGpPWpGaD
Afatinib—ABL1—Immune System—CD8A—atopic dermatitis	4.97e-05	0.000189	CbGpPWpGaD
Afatinib—ERBB4—Immune System—CD4—atopic dermatitis	4.97e-05	0.000189	CbGpPWpGaD
Afatinib—BLK—Immune System—IFNG—atopic dermatitis	4.95e-05	0.000188	CbGpPWpGaD
Afatinib—IRAK1—Immune System—NFKBIA—atopic dermatitis	4.92e-05	0.000187	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—CASP8—atopic dermatitis	4.91e-05	0.000187	CbGpPWpGaD
Afatinib—ABL1—Innate Immune System—CD4—atopic dermatitis	4.9e-05	0.000186	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—CXCL10—atopic dermatitis	4.84e-05	0.000184	CbGpPWpGaD
Afatinib—BLK—Immune System—CD4—atopic dermatitis	4.78e-05	0.000182	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—CCL5—atopic dermatitis	4.71e-05	0.000179	CbGpPWpGaD
Afatinib—ERBB2—Innate Immune System—IL6—atopic dermatitis	4.68e-05	0.000178	CbGpPWpGaD
Afatinib—ERBB2—Immune System—IL1B—atopic dermatitis	4.66e-05	0.000177	CbGpPWpGaD
Afatinib—ERBB2—Disease—CD4—atopic dermatitis	4.65e-05	0.000177	CbGpPWpGaD
Afatinib—ERBB2—Immune System—IL2—atopic dermatitis	4.64e-05	0.000177	CbGpPWpGaD
Afatinib—ERBB4—Innate Immune System—IL6—atopic dermatitis	4.61e-05	0.000176	CbGpPWpGaD
Afatinib—ERBB4—Immune System—IL1B—atopic dermatitis	4.59e-05	0.000175	CbGpPWpGaD
Afatinib—ERBB4—Disease—CD4—atopic dermatitis	4.58e-05	0.000175	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—CCR3—atopic dermatitis	4.58e-05	0.000174	CbGpPWpGaD
Afatinib—ERBB4—Immune System—IL2—atopic dermatitis	4.57e-05	0.000174	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—GLB1—atopic dermatitis	4.47e-05	0.00017	CbGpPWpGaD
Afatinib—IRAK1—Immune System—CASP8—atopic dermatitis	4.44e-05	0.000169	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—CCR3—atopic dermatitis	4.41e-05	0.000168	CbGpPWpGaD
Afatinib—BLK—Immune System—IL1B—atopic dermatitis	4.41e-05	0.000168	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—NFKBIA—atopic dermatitis	4.4e-05	0.000167	CbGpPWpGaD
Afatinib—BLK—Immune System—IL2—atopic dermatitis	4.39e-05	0.000167	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—NFKBIA—atopic dermatitis	4.33e-05	0.000165	CbGpPWpGaD
Afatinib—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	4.33e-05	0.000165	CbGpPWpGaD
Afatinib—EGFR—Immune System—IL18—atopic dermatitis	4.31e-05	0.000164	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—ADSL—atopic dermatitis	4.29e-05	0.000163	CbGpPWpGaD
Afatinib—ERBB2—Immune System—MAPK8—atopic dermatitis	4.27e-05	0.000163	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—CCR5—atopic dermatitis	4.25e-05	0.000162	CbGpPWpGaD
Afatinib—EGFR—Immune System—CD8A—atopic dermatitis	4.24e-05	0.000162	CbGpPWpGaD
Afatinib—ERBB4—Immune System—MAPK8—atopic dermatitis	4.2e-05	0.00016	CbGpPWpGaD
Afatinib—ABL1—Axon guidance—IL6—atopic dermatitis	4.2e-05	0.00016	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—CD4—atopic dermatitis	4.18e-05	0.000159	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—CCL5—atopic dermatitis	4.16e-05	0.000159	CbGpPWpGaD
Afatinib—LCK—Immune System—IL18—atopic dermatitis	4.15e-05	0.000158	CbGpPWpGaD
Afatinib—ABL1—Innate Immune System—MAPK8—atopic dermatitis	4.15e-05	0.000158	CbGpPWpGaD
Afatinib—LCK—Hemostasis—IL2—atopic dermatitis	4.12e-05	0.000157	CbGpPWpGaD
Afatinib—LCK—Immune System—CD8A—atopic dermatitis	4.09e-05	0.000156	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—TAC1—atopic dermatitis	4.08e-05	0.000155	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—NPS—atopic dermatitis	4.08e-05	0.000155	CbGpPWpGaD
Afatinib—BLK—Immune System—MAPK8—atopic dermatitis	4.04e-05	0.000154	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—CD4—atopic dermatitis	4.03e-05	0.000153	CbGpPWpGaD
Afatinib—EGFR—Adaptive Immune System—CD4—atopic dermatitis	4.02e-05	0.000153	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—CXCR3—atopic dermatitis	4e-05	0.000152	CbGpPWpGaD
Afatinib—EGFR—Signaling by NGF—IL6—atopic dermatitis	3.97e-05	0.000151	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—TAC1—atopic dermatitis	3.93e-05	0.00015	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—NPS—atopic dermatitis	3.93e-05	0.00015	CbGpPWpGaD
Afatinib—LCK—Cytokine Signaling in Immune system—IL6—atopic dermatitis	3.89e-05	0.000148	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—CD4—atopic dermatitis	3.87e-05	0.000147	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—NGF—atopic dermatitis	3.86e-05	0.000147	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—CXCR3—atopic dermatitis	3.86e-05	0.000147	CbGpPWpGaD
Afatinib—ABL1—Immune System—NFKBIA—atopic dermatitis	3.85e-05	0.000147	CbGpPWpGaD
Afatinib—LCK—Signaling by NGF—IL6—atopic dermatitis	3.82e-05	0.000146	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—IL5—atopic dermatitis	3.79e-05	0.000144	CbGpPWpGaD
Afatinib—IRAK1—Immune System—IFNG—atopic dermatitis	3.77e-05	0.000144	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—CCR5—atopic dermatitis	3.75e-05	0.000143	CbGpPWpGaD
Afatinib—ABL1—Developmental Biology—TNF—atopic dermatitis	3.72e-05	0.000141	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—IL5—atopic dermatitis	3.66e-05	0.000139	CbGpPWpGaD
Afatinib—IRAK1—Immune System—CD4—atopic dermatitis	3.64e-05	0.000139	CbGpPWpGaD
Afatinib—EGFR—Axon guidance—IL6—atopic dermatitis	3.59e-05	0.000137	CbGpPWpGaD
Afatinib—EGFR—Disease—CCR5—atopic dermatitis	3.58e-05	0.000136	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—MAPK8—atopic dermatitis	3.54e-05	0.000135	CbGpPWpGaD
Afatinib—ABL1—Immune System—CASP8—atopic dermatitis	3.47e-05	0.000132	CbGpPWpGaD
Afatinib—LCK—Disease—CCR5—atopic dermatitis	3.45e-05	0.000131	CbGpPWpGaD
Afatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	3.43e-05	0.00013	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—MAPK8—atopic dermatitis	3.41e-05	0.00013	CbGpPWpGaD
Afatinib—IRAK1—Innate Immune System—IL6—atopic dermatitis	3.38e-05	0.000129	CbGpPWpGaD
Afatinib—IRAK1—Immune System—IL1B—atopic dermatitis	3.37e-05	0.000128	CbGpPWpGaD
Afatinib—IRAK1—Immune System—IL2—atopic dermatitis	3.35e-05	0.000128	CbGpPWpGaD
Afatinib—EGFR—Immune System—NFKBIA—atopic dermatitis	3.29e-05	0.000125	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—CXCL10—atopic dermatitis	3.24e-05	0.000123	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—NFKBIA—atopic dermatitis	3.18e-05	0.000121	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—TNF—atopic dermatitis	3.17e-05	0.000121	CbGpPWpGaD
Afatinib—LCK—Immune System—NFKBIA—atopic dermatitis	3.17e-05	0.000121	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—CXCL8—atopic dermatitis	3.14e-05	0.000119	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—CXCL10—atopic dermatitis	3.12e-05	0.000119	CbGpPWpGaD
Afatinib—ABCB1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	3.1e-05	0.000118	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—CXCL8—atopic dermatitis	3.09e-05	0.000118	CbGpPWpGaD
Afatinib—IRAK1—Immune System—MAPK8—atopic dermatitis	3.09e-05	0.000117	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—IL2—atopic dermatitis	3e-05	0.000114	CbGpPWpGaD
Afatinib—ABL1—Developmental Biology—IL6—atopic dermatitis	3e-05	0.000114	CbGpPWpGaD
Afatinib—EGFR—Immune System—CASP8—atopic dermatitis	2.97e-05	0.000113	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—IL2—atopic dermatitis	2.95e-05	0.000112	CbGpPWpGaD
Afatinib—ABL1—Immune System—IFNG—atopic dermatitis	2.95e-05	0.000112	CbGpPWpGaD
Afatinib—LCK—Immune System—CASP8—atopic dermatitis	2.86e-05	0.000109	CbGpPWpGaD
Afatinib—ABL1—Immune System—CD4—atopic dermatitis	2.85e-05	0.000109	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—CCL5—atopic dermatitis	2.78e-05	0.000106	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—MAPK8—atopic dermatitis	2.76e-05	0.000105	CbGpPWpGaD
Afatinib—ERBB2—Immune System—IL6—atopic dermatitis	2.73e-05	0.000104	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—MAPK8—atopic dermatitis	2.72e-05	0.000103	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—PPARA—atopic dermatitis	2.69e-05	0.000102	CbGpPWpGaD
Afatinib—ERBB4—Immune System—IL6—atopic dermatitis	2.69e-05	0.000102	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—CCL5—atopic dermatitis	2.68e-05	0.000102	CbGpPWpGaD
Afatinib—ABL1—Innate Immune System—IL6—atopic dermatitis	2.65e-05	0.000101	CbGpPWpGaD
Afatinib—ABL1—Immune System—IL1B—atopic dermatitis	2.63e-05	0.0001	CbGpPWpGaD
Afatinib—ABL1—Immune System—IL2—atopic dermatitis	2.62e-05	9.99e-05	CbGpPWpGaD
Afatinib—BLK—Immune System—IL6—atopic dermatitis	2.58e-05	9.83e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—NGF—atopic dermatitis	2.58e-05	9.82e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—CXCL8—atopic dermatitis	2.57e-05	9.77e-05	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—IL6—atopic dermatitis	2.56e-05	9.75e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—IFNG—atopic dermatitis	2.52e-05	9.61e-05	CbGpPWpGaD
Afatinib—ERBB2—Disease—IL6—atopic dermatitis	2.52e-05	9.58e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—CCR5—atopic dermatitis	2.51e-05	9.55e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—NGF—atopic dermatitis	2.49e-05	9.46e-05	CbGpPWpGaD
Afatinib—ABCB1—head—atopic dermatitis	2.49e-05	0.0126	CbGeAlD
Afatinib—ERBB4—Disease—IL6—atopic dermatitis	2.48e-05	9.44e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—IL2—atopic dermatitis	2.45e-05	9.34e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—CD4—atopic dermatitis	2.44e-05	9.28e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—IFNG—atopic dermatitis	2.43e-05	9.26e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—CCR5—atopic dermatitis	2.42e-05	9.2e-05	CbGpPWpGaD
Afatinib—ABL1—Immune System—MAPK8—atopic dermatitis	2.42e-05	9.19e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—CD4—atopic dermatitis	2.35e-05	8.94e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—CXCL8—atopic dermatitis	2.27e-05	8.64e-05	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—IL6—atopic dermatitis	2.26e-05	8.61e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—IL1B—atopic dermatitis	2.25e-05	8.57e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—CD4—atopic dermatitis	2.25e-05	8.56e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—IL2—atopic dermatitis	2.24e-05	8.54e-05	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—IL6—atopic dermatitis	2.18e-05	8.3e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—IL1B—atopic dermatitis	2.17e-05	8.26e-05	CbGpPWpGaD
Afatinib—LCK—Disease—CD4—atopic dermatitis	2.17e-05	8.25e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—IL2—atopic dermatitis	2.17e-05	8.25e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—IL2—atopic dermatitis	2.16e-05	8.23e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—NFKBIA—atopic dermatitis	2.13e-05	8.1e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—MAPK8—atopic dermatitis	2.06e-05	7.86e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—NFKBIA—atopic dermatitis	2.05e-05	7.8e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—MAPK8—atopic dermatitis	2e-05	7.6e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—MAPK8—atopic dermatitis	1.99e-05	7.57e-05	CbGpPWpGaD
Afatinib—IRAK1—Immune System—IL6—atopic dermatitis	1.97e-05	7.5e-05	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—IL6—atopic dermatitis	1.76e-05	6.71e-05	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—IL6—atopic dermatitis	1.74e-05	6.61e-05	CbGpPWpGaD
Afatinib—ABL1—Immune System—IL6—atopic dermatitis	1.54e-05	5.87e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—CXCL8—atopic dermatitis	1.52e-05	5.77e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—CXCL8—atopic dermatitis	1.46e-05	5.56e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—PPARA—atopic dermatitis	1.45e-05	5.53e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—IL2—atopic dermatitis	1.45e-05	5.52e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—IL6—atopic dermatitis	1.44e-05	5.49e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—IL2—atopic dermatitis	1.4e-05	5.32e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—MAPK8—atopic dermatitis	1.33e-05	5.08e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—IL6—atopic dermatitis	1.32e-05	5.02e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—MAPK8—atopic dermatitis	1.29e-05	4.9e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—IL6—atopic dermatitis	1.27e-05	4.85e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—IL6—atopic dermatitis	1.27e-05	4.83e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—IL6—atopic dermatitis	1.22e-05	4.63e-05	CbGpPWpGaD
Afatinib—LCK—Disease—IL6—atopic dermatitis	1.17e-05	4.46e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—IL6—atopic dermatitis	8.52e-06	3.24e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—IL6—atopic dermatitis	8.21e-06	3.13e-05	CbGpPWpGaD
